Type 1 Diabetes Management - Search News

News

type 2 diabetes, weight loss and GLP-1

CBS News on MSN · 18h

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

ABC News · 21h

New weight loss pill could benefit people with Type 2 diabetes: Drugmaker

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.

Fox News on MSN · 18h

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

MarketersMEDIA Newsroom10d

Type 1 Diabetes Effective Management Strategies: Lifestyle Guide Published

Valleant, a collective of health educators, has published a new guide on management strategies for type 1 diabetes.

The Fresh Toast19h

Diabetes And Cannabis

The Fresh Toast - It is the news and over 42 million suffer from it in Canada and the US, but what is the link between ...

Scot Scoop News3d

Living with Type 1 diabetes

High school life is a fragile juggling act of managing painstaking amounts of schoolwork, meeting the demands of ...

The American Journal of Managed Care3d

Tirzepatide Surges, Overtakes Older Drugs in Diabetes, Obesity Care

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results